# Shin Poong Pharmaceutical Co. Ltd.

Organization · id `cardio:org-shin-poong-pharmaceutical-co-ltd` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Shin+Poong+Pharmaceutical+Co.+Ltd.>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Shin Poong Pharmaceutical Co. Ltd.
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension (`cardio:ct-nct02944734`)
- Sponsors: The Efficacy and Safety of Combination Therapy of Rosuvastatin and Ezetimibe and Rosuvastatin Monotherapy in Patients With Primary Hypercholesterolemia (`cardio:ct-nct03288038`)
- Sponsors: Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA (`cardio:ct-nct04479449`)
- Sponsors: Evaluate the Efficacy and Safety of SPC1001 and Monotherapy in Patients With Essential Hypertension (`cardio:ct-nct06212648`)
- Sponsors: Efficacy and Safety of SP-8203 (Otaplimastat) in Patients With Acute Ischemic Stroke Receiving Thrombolytic Standard of Care (`cardio:ct-nct06660719`)
- Sponsors: Efficacy and Safety of SPC1001 in Patients With Essential Hypertension (`cardio:ct-nct06826872`)
- Sponsors: Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension (`cardio:ct-nct07064525`)

## Provenance

Content hash: a408f86c2fce4bc93d6203db9a7d5045253c003e21019fff8c03d2d66a8c7827
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
